Tasso Launches Integrated Population Pharmacokinetic Solutions to Optimize, Scale, and Accelerate Decentralized Clinical Trials

New integrated Tasso PopPK Solutions provide pharmaceutical companies with a seamless workflow for accurate acquisition of PopPK data

Tasso, Inc., a leader in clinical-grade blood collection solutions, announced the launch of Tasso PopPK Solutions, an integrated patient-centric offering for population pharmacokinetics (PopPK). With the launch of Tasso PopPK Solutions, Tasso now enables pharmaceutical companies to operationalize pharmacokinetic studies as part of their decentralized clinical trial efforts. Tasso’s remote solution supports the scalable and convenient acquisition of pharmacokinetic data, improving modeling accuracy and accelerating clinical trials.

Latest Aithority Insights: Immuta and Starburst Expand Partnership to Meet Demands for Secure Data Access

“Tasso is uniquely positioned to deliver accurate, patient-centric sampling for PopPK studies, at home or in the research clinic. With the launch of our dedicated PopPK Solutions, programs can efficiently operationalize remote sampling.”

PopPK is a well-established mathematical modeling methodology for understanding the observed variability in circulating drug concentrations among individuals. Tasso’s PopPK Solutions combine the company’s signature blood collection devices with the data monitoring solutions required for accurate pharmacokinetic (PK) modeling, including timestamping, customizable patient engagement tools, and chain-of-custody monitoring. The patient-centric, virtually painless sample collection process can help to improve recruitment and retention by enhancing user experience, which leads to increased data density and fidelity.

Browse The Complete News About Aithority : Socure and ServiceNow Create Banking Experience of the Future

“Our pharma partners have been seeking decentralized solutions to enhance their study adherence and to facilitate inclusion of more diverse populations,” said Erwin Berthier, PhD, CTO and co-founder of Tasso. “Tasso is uniquely positioned to deliver accurate, patient-centric sampling for PopPK studies, at home or in the research clinic. With the launch of our dedicated PopPK Solutions, programs can efficiently operationalize remote sampling.”

Read More About Aithority News Exabeam OEMs ZeroFox to Enhance Threat Intelligence

[To share your insights with us, please write to sghosh@martechseries.com]